Trident Texofab opened higher at ₹23.68, compared with its previous close of ₹22.57. In the last trading session on 12 Nov 2026, the stock traded between ₹23.02 and ₹23.69, with an average traded price of ₹23.60. It showed an upward intraday trend.
An investment of ₹10,000 made 5 years ago in Trident Texofab is now worth
₹ 5,509.00
Resulting in a loss of
₹ 4,491.00 (44.91%)
Note: Past profits do not guarantee future returns.
No analyst rating data available.
Today's Change
+1.12 (+4.96%)
Day High
₹23.69
Day Low
₹23.02
Day Open
₹23.68
Prev Close
₹22.57
Volume
23,623
Value Traded
₹0.06 Cr
1W Return
6.14%
1M Return
18.45%
3M Return
5.76%
6M Return
-54.38%
1Y Return
-92.51%
Market Cap (₹ Cr.)
35
PE Ratio
-107.50
PB Ratio
0.60
Dividend Yield
-
ROE
1.27%
ROCE
5.69%
Book Value (₹)
37.82
Face Value (₹)
10.00
EPS (TTM)
-
Industry PE
-
Beta
-
Debt to Equity
-
1 Week
6.14%
6 Weeks
-
1 Month
18.45%
3 Months
5.76%
9 Months
-82.90%
No data available.
Trident Texofab Q2FY27 Results: Revenue falls 17% YoY to ₹25.34 crore
Revenue from operations fell 17% YoY to ₹25.34 crore in Q2FY27. Net profit declined to ₹60.40 lakh from ₹112.77 lakh in the prior year quarter. Other income jumped to ₹1.50 crore, up from ₹0.39 crore YoY. Trade receivables reduced to ₹36.00 crore from ₹48.55 crore as of March 31, 2026. Total assets grew to ₹117.38 crore, supported by higher borrowings.
7 days agoTrident Texofab shareholders approve statutory auditor appointment
Resolution passed with 100% votes in favour (6,021,874 votes). Zero votes cast against the auditor appointment. Promoters voted 2,808,620 shares; public non-institutions voted 3,213,254 shares. EGM held via video conferencing on October 28, 2026.
14 days agoTrident Texofab EGM on Oct 28 to ratify auditor appointment
Trident Texofab schedules EGM on October 28, 2026, via VC/OAVM. Agenda: Ratify appointment of A Bafna & Associates as statutory auditor. Previous auditor Shah Kailash & Associates LLP resigned causing vacancy. Remote e-voting window opens October 25, 2026, closes October 27, 2026.
1mo agoHardik Desai Family Trust acquires 5,412 shares in Trident Texofab
Hardik Desai Family Trust acquired 5,412 equity shares in the open market. Promoter group stake increased from 6.95% to 6.99%. Transaction date recorded as September 21, 2026. Total equity capital remained unchanged at ₹14,99,57,640.
1mo agoTrident Texofab schedules AGM for September 30 to approve FY26 results
Trident Texofab scheduled its 18th AGM for September 30, 2026, to approve FY26 results. Remote e-voting opens on September 27 and closes on September 29, 2026. Board recommends reappointment of director Manish Halwawala who retires by rotation. Shareholders to approve related party transactions up to ₹25 crore with group entities.
2mo agoHardik Desai Family Trust buys 8,643 Trident Texofab shares
Hardik Desai Family Trust acquired 8,643 shares of Trident Texofab in the open market. Stake increased from 6.89% to 6.95%, totaling 10,42,334 shares held. Transaction disclosed under SEBI SAST Regulation 29(2) on August 26, 2026. Total equity capital remains at ₹14,99,57,640 with no change in share count.
2mo ago| Stock | LTP | Change % | Market Cap (Cr.) | PE | 1Y Return |
|---|---|---|---|---|---|
| ₹1,182.60 | +2.85% | ₹40,422.92 | 37.90 | +8.57% | |
| ₹31,705.00 | -0.46% | ₹35,363.36 | 47.30 | -22.14% | |
| ₹250.94 | +1.34% | ₹23,707.62 | 53.00 | +80.12% | |
| ₹521.50 | +0.29% | ₹15,101.43 | 14.60 | +16.58% | |
| ₹506.70 | +0.07% | ₹13,784.30 | 29.00 | +52.37% | |
| ₹1,351.60 | -1.36% | ₹12,486.23 | 35.60 | +59.61% | |
| ₹23.62 | -0.63% | ₹12,036.65 | 25.30 | -18.33% | |
| ₹549.70 | -1.12% | ₹10,887.05 | 45.20 | +75.12% | |
| ₹727.95 | +1.20% | ₹7,108.31 | 29.70 | +0.74% | |
| ₹414.50 | -0.07% | ₹5,863.53 | 28.30 | +3.34% | |
| ₹549.50 | +0.01% | ₹5,769.28 | 35.10 | +31.15% | |
| ₹676.10 | +0.77% | ₹4,954.30 | 36.20 | -25.87% |
An investment of ₹10,000 made 5 years ago in Trident Texofab is now worth
₹ 5,509.00
Resulting in a loss of
₹ 4,491.00 (44.91%)
Note: Past profits do not guarantee future returns.
